ASTHMA
Clinical trials for ASTHMA explained in plain language.
Never miss a new study
Get alerted when new ASTHMA trials appear
Sign up with your email to follow new studies for ASTHMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Virtual coach aims to cut asthma emergencies in children
Disease control OngoingThis study looks at how well a virtual program called Coach McLungs works when used in regular doctor visits for children with asthma. The program helps doctors and families make decisions together and provides asthma education. Researchers will track whether kids have fewer asth…
Matched conditions: ASTHMA
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated May 26, 2026 04:11 UTC
-
New triple inhaler shows promise for Hard-to-Control asthma
Disease control OngoingThis study tests whether a new triple-combination inhaler (FF/UMEC/VI) works better than the usual two-medication inhaler (ICS/LABA) for adults whose asthma is not well controlled. About 1,366 participants will use one of the two treatments for 24 weeks, and researchers will meas…
Matched conditions: ASTHMA
Phase: PHASE4 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 26, 2026 04:10 UTC
-
New online tool aims to help teens breathe easier
Disease control OngoingThis study tests a web-based program called CAMP Air designed to help urban teens with uncontrolled asthma. About 374 Black and Hispanic adolescents will use the program to improve symptom control and reduce emergency visits. The goal is to see if an online approach can make asth…
Matched conditions: ASTHMA
Phase: NA • Sponsor: Columbia University • Aim: Disease control
Last updated May 26, 2026 04:08 UTC
-
New wearable could help kids breathe easier at home
Disease control OngoingThis study tests a wearable device called AeviceMD that monitors breathing in children with poorly controlled asthma. Twenty kids aged 3 to 18 will use the device at home to track their respiratory health. The goal is to help families manage asthma better and allow doctors to adj…
Matched conditions: ASTHMA
Phase: NA • Sponsor: Irina Dralyuk • Aim: Disease control
Last updated May 26, 2026 04:08 UTC
-
New antibody shows promise for severe asthma sufferers
Disease control OngoingThis study tests a new antibody drug (610) for adults with severe eosinophilic asthma, a type of asthma linked to high levels of certain white blood cells. The goal is to see if adding this drug to standard treatment improves lung function and reduces asthma attacks over 52 weeks…
Matched conditions: ASTHMA
Phase: PHASE2 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 04:07 UTC
-
New asthma drug shows promise in phase 2 trial
Disease control OngoingThis study tests a new medicine, GSK5784283, for adults aged 18 to 75 whose asthma is not well controlled despite regular treatments. The drug blocks a protein called TSLP that may cause inflammation. The trial has two parts: first to find the best dose by checking lung function …
Matched conditions: ASTHMA
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 26, 2026 04:06 UTC
-
New hope for asthma sufferers: drug combo may beat higher inhaler doses
Disease control OngoingThis study looks at 120 adults with asthma that is not well controlled by their current medium-dose inhaler. Researchers want to see if adding the injectable drug dupilumab to the usual inhaler works better than simply increasing the inhaler dose. The goal is to reduce severe ast…
Matched conditions: ASTHMA
Phase: PHASE4 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 04:04 UTC
-
New drug may stop asthma attacks in city kids
Disease control OngoingThis study tests whether adding dupilumab to standard asthma care can prevent asthma attacks in 240 children and teens (ages 6-17) living in urban areas who have frequent asthma attacks. Participants receive either dupilumab or a placebo for 12 months, and researchers count how m…
Matched conditions: ASTHMA
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 26, 2026 04:04 UTC
-
New hope for asthma patients: drug may slow lung damage over 3 years
Disease control OngoingThis study tests whether dupilumab, an injectable drug, can slow the long-term decline in lung function for adults with moderate to severe asthma that is not well controlled by current treatments. About 1,300 participants will receive either dupilumab or a placebo for 3 years, al…
Matched conditions: ASTHMA
Phase: PHASE4 • Sponsor: Sanofi • Aim: Disease control
Last updated May 26, 2026 04:03 UTC
-
Gene-Guided asthma treatment shows promise in new trial
Disease control OngoingThis study looks at whether people aged 12 and older with a specific gene change (IL-4RαR576) get more help from the drug dupilumab to control their asthma. Over 48 weeks, researchers will count how many severe asthma attacks happen and check lung function. The goal is to see if …
Matched conditions: ASTHMA
Phase: PHASE4 • Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated May 26, 2026 03:57 UTC
-
New drug shows promise in cutting asthma attacks
Disease control OngoingThis study tests an experimental drug called rocatinlimab in 317 adults with moderate-to-severe asthma. The goal is to see if it can reduce the number of asthma attacks when added to standard inhaler therapy. Participants receive either the drug or a placebo, and researchers trac…
Matched conditions: ASTHMA
Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control
Last updated May 26, 2026 03:57 UTC
-
Can a smart device help kids with asthma breathe easier?
Disease control OngoingThis study looks at whether a smart spacer device can help children and young people (ages 6-18) with asthma use their inhalers correctly. Many kids don't use their inhalers the right way, leading to poor asthma control. The study will randomly assign participants to receive eith…
Matched conditions: ASTHMA
Phase: NA • Sponsor: University Hospitals of North Midlands NHS Trust • Aim: Disease control
Last updated May 26, 2026 03:56 UTC
-
Asthma attack Follow-Up clinic aims to cut severe Flare-Ups
Disease control ENROLLING_BY_INVITATIONThis study looks at whether a structured follow-up clinic for adults after an asthma attack improves disease management and reduces future severe attacks. 230 participants will either attend in-person clinic visits or receive phone follow-ups. The goal is to see if the clinic hel…
Matched conditions: ASTHMA
Phase: NA • Sponsor: Tel-Aviv Sourasky Medical Center • Aim: Disease control
Last updated May 26, 2026 03:55 UTC
-
New asthma drug tested for long-term safety in 335 adults
Disease control OngoingThis study looks at the long-term safety and effectiveness of a drug called amlitelimab for adults with moderate-to-severe asthma. Participants had already completed a previous amlitelimab study. The goal is to see if the drug remains safe and helps control asthma over up to 144 …
Matched conditions: ASTHMA
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated May 26, 2026 03:52 UTC
-
New asthma drug shows promise in Mid-Stage trial
Disease control OngoingThis study tests an experimental drug, solrikitug, in 145 adults with asthma who still have symptoms despite using standard inhalers. The main goal is to see if the drug can lower certain immune cells (eosinophils) in the blood, which are linked to asthma attacks. Participants re…
Matched conditions: ASTHMA
Phase: PHASE2 • Sponsor: Uniquity One (UNI) • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New study offers hope for asthma patients who forget their daily inhalers
Disease control OngoingThis study looks at a different way to use asthma inhalers for people who often forget to take their daily maintenance inhaler. Instead of using a daily inhaler, participants will use a combination inhaler only when they have symptoms. The goal is to see if this approach helps pe…
Matched conditions: ASTHMA
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New drug shows promise for severe asthma sufferers
Disease control OngoingThis study tests a drug called benralizumab in 75 adults with severe asthma that is not well controlled by standard inhalers. The goal is to see if the drug can reduce airway inflammation and improve lung structure and function over 48 weeks. Participants continue their usual ast…
Matched conditions: ASTHMA
Phase: PHASE4 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New asthma drug tezepelumab put to the test in Real-Life greek clinics
Disease control OngoingThis study follows 155 people with severe asthma who are starting a new medicine called tezepelumab. Researchers want to see how well it controls asthma symptoms and improves quality of life over two years in real-world clinics across Greece. The goal is to understand if this tre…
Matched conditions: ASTHMA
Sponsor: AstraZeneca • Aim: Disease control
Last updated May 18, 2026 12:09 UTC
-
Asthma study pulled before it started: comparing two drug plans
Disease control TerminatedThis study aimed to compare two treatment options for adults with T2-high asthma that remains uncontrolled despite using a medium-dose inhaler combination. The two options were increasing the dose of the inhaled corticosteroid or adding a third medication (triple therapy). The go…
Matched conditions: ASTHMA
Phase: PHASE4 • Sponsor: Galaxia Empírica • Aim: Disease control
Last updated May 18, 2026 12:03 UTC
-
Could a simple inhaler switch prevent severe asthma attacks?
Disease control OngoingThis study looks at whether changing the rescue inhaler from albuterol alone to albuterol plus budesonide can lower the number of severe asthma attacks. About 1,500 adults with asthma who have had at least one severe attack in the past year will switch to the new inhaler. Researc…
Matched conditions: ASTHMA
Phase: PHASE4 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 08, 2026 12:02 UTC
-
Asthma inhaler upgrade: new propellant put to the test
Disease control OngoingThis study checks if a new version of a common asthma inhaler works just as well as the current one. About 422 adults with asthma will use both inhalers and a placebo to compare lung function. The goal is to make sure the new propellant is safe and effective.
Matched conditions: ASTHMA
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 07, 2026 18:41 UTC
-
C-Section babies get a microbiome boost to fight allergies
Prevention OngoingThis study looks at whether giving C-section babies a dose of their mother's vaginal bacteria can lower their risk of developing allergies and asthma. Researchers believe that babies born by C-section miss out on beneficial bacteria that help train the immune system. The study in…
Matched conditions: ASTHMA
Phase: EARLY_PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Prevention
Last updated May 26, 2026 03:57 UTC
-
Asthma prevention breakthrough? drug shows promise in High-Risk toddlers
Prevention OngoingThis study tests whether a drug called omalizumab can prevent asthma from developing in young children at high risk. The trial involves 200 children aged 2-3 years old who have had wheezing episodes and allergies. They receive the drug or a placebo for two years, then are monitor…
Matched conditions: ASTHMA
Phase: PHASE2 • Sponsor: Boston Children's Hospital • Aim: Prevention
Last updated May 19, 2026 12:00 UTC
-
Prenatal vitamin d may shield kids from asthma
Prevention OngoingThis study looks at whether giving pregnant mothers extra vitamin D can prevent asthma symptoms like wheezing in their children. About 600 mothers from a Danish asthma study took either a high dose (2400 IU) of vitamin D or a placebo daily from week 24 of pregnancy until one week…
Matched conditions: ASTHMA
Phase: PHASE1 • Sponsor: Copenhagen Studies on Asthma in Childhood • Aim: Prevention
Last updated May 18, 2026 12:02 UTC
-
Gut health fix? probiotics may ease asthma in obese patients
Symptom relief OngoingThis small pilot study tests whether taking oral probiotics for 12 weeks can improve asthma control and insulin resistance in obese adults with asthma. Researchers will measure changes in gut and airway bacteria, inflammation, and breathing tests. Only 7 participants are enrolled…
Matched conditions: ASTHMA
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated May 26, 2026 04:09 UTC
-
New asthma and COPD drug enters first human safety tests
Symptom relief OngoingThis early-stage study tests a new medicine called GB-0895 in adults with mild-to-moderate asthma or COPD. The main goal is to check if the drug is safe and how the body handles it. About 156 participants will receive either the drug or a placebo. This research is a first step to…
Matched conditions: ASTHMA
Phase: PHASE1 • Sponsor: Generate Biomedicines • Aim: Symptom relief
Last updated May 26, 2026 04:07 UTC
-
Smart inhaler coach aims to tame asthma
Symptom relief OngoingThis study tests a digital platform called aflo™ that attaches to asthma inhalers to give real-time feedback on technique and medication reminders. About 26 children and adults with uncontrolled asthma will use the device for 3 months. The goal is to see if it improves how well t…
Matched conditions: ASTHMA
Phase: NA • Sponsor: Boston Children's Hospital • Aim: Symptom relief
Last updated May 26, 2026 04:06 UTC
-
Asthma breathing study pulled before it even started
Symptom relief TerminatedThis study planned to test whether osteopathic manipulative treatment (OMT) — a hands-on technique to improve chest movement — could reduce lung inflammation and improve breathing in adults with asthma. About 100 participants would have been enrolled, but the study was withdrawn …
Matched conditions: ASTHMA
Phase: NA • Sponsor: University Hospitals Cleveland Medical Center • Aim: Symptom relief
Last updated May 26, 2026 04:02 UTC
-
Asthma drug may boost daily steps in severe cases
Symptom relief OngoingThis study looks at whether mepolizumab, a drug already used to reduce asthma attacks, can also help people with severe asthma become more physically active. Researchers will track daily steps and exercise tolerance in 62 adults over six months. The goal is to see if the treatmen…
Matched conditions: ASTHMA
Sponsor: University Hospital, Lille • Aim: Symptom relief
Last updated May 26, 2026 03:53 UTC
-
HEPA purifiers may ease asthma in overweight kids
Symptom relief OngoingThis study looks at whether using HEPA air purifiers at home can improve asthma symptoms in children, and if overweight kids benefit more. About 200 children with asthma from Baltimore, half overweight and half normal weight, will receive either real or fake air purifiers. The go…
Matched conditions: ASTHMA
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated May 26, 2026 03:53 UTC
-
New program helps 9/11 heroes breathe easier
Symptom relief OngoingThis study tests a program called SaMBA-WTC to help World Trade Center responders with asthma better manage their condition. About 56 adults with uncontrolled asthma will receive either the program or general health information. The goal is to see if the program improves asthma c…
Matched conditions: ASTHMA
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated May 26, 2026 03:52 UTC
-
New asthma drug APG777 enters early human testing
Symptom relief OngoingThis study tests a new drug called APG777 in 31 adults with mild-to-moderate asthma. The main goal is to check if the drug is safe and how the body processes it. Participants receive either the drug or a placebo, and researchers monitor for side effects and measure drug levels in…
Matched conditions: ASTHMA
Phase: PHASE1 • Sponsor: Apogee Therapeutics, Inc. • Aim: Symptom relief
Last updated May 26, 2026 03:51 UTC
-
Asthma study pulled before it started: would extra steroid help kids?
Symptom relief TerminatedThis study aimed to see if giving children with asthma a nebulized steroid (budesonide) after an emergency room visit, on top of standard oral steroids, could reduce the chance of another attack within a month. It planned to enroll children aged 2 to 8 who had an asthma flare-up …
Matched conditions: ASTHMA
Phase: PHASE4 • Sponsor: Phoenix Children's Hospital • Aim: Symptom relief
Last updated May 18, 2026 12:11 UTC
-
New study aims to help black women with asthma get active and gain control
Symptom relief OngoingThis study tests a 24-week physical activity program designed specifically for Black women with asthma. The goal is to see if the program improves asthma control and quality of life compared to standard asthma education. About 224 women will take part, and researchers will also c…
Matched conditions: ASTHMA
Phase: NA • Sponsor: University of Chicago • Aim: Symptom relief
Last updated May 18, 2026 12:08 UTC
-
New questionnaire aims to spot hidden lung issues in COPD patients
Knowledge-focused OngoingThis study works to create a simple questionnaire that helps doctors find small airway problems in people with COPD. Researchers will test the questionnaire on 108 adults and compare it with standard breathing tests. The goal is to make diagnosis easier and more accurate in every…
Matched conditions: ASTHMA
Sponsor: General Practitioners Research Institute • Aim: Knowledge-focused
Last updated May 26, 2026 04:07 UTC
-
New digital platform aims to cut errors when patients are transferred between hospitals
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests a new digital platform that helps hospitals share patient information more reliably when a patient is transferred from one hospital to another. About 1,000 adults being moved to Brigham and Women's Hospital from three other hospitals will take part. The goal is t…
Matched conditions: ASTHMA
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 04:04 UTC
-
Asthma insights: 1,073 patients help unlock disease patterns
Knowledge-focused OngoingThis observational study looks at over 1,000 adults with asthma to better understand different disease types and how well treatments work. Researchers will use real-world data and genetic information to describe asthma subtypes and track who responds to therapy. The goal is to im…
Matched conditions: ASTHMA
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated May 26, 2026 04:04 UTC
-
Asthma mucus plug removal study halted before start
Knowledge-focused TerminatedThis study aimed to see if removing mucus plugs from the airways using a scope (bronchoscopy) is safe and improves lung function in people with asthma. It planned to enroll adults aged 18-70 with asthma and low lung function. However, the study was withdrawn before any participan…
Matched conditions: ASTHMA
Phase: NA • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated May 26, 2026 03:58 UTC
-
New study tracks RSV spread from mom to baby during pregnancy
Knowledge-focused OngoingThis study looks at whether the respiratory syncytial virus (RSV) can pass from a pregnant woman to her unborn baby. Researchers will test blood from mothers and umbilical cords to check for RSV and other viruses. They will also follow the babies for up to 4 years to see if they …
Matched conditions: ASTHMA
Sponsor: Tulane University • Aim: Knowledge-focused
Last updated May 26, 2026 03:57 UTC
-
COVID-19's toll on asthma: new study aims to uncover hidden lung damage
Knowledge-focused TerminatedThis study was designed to see if COVID-19 makes asthma worse or changes how well patients can control their asthma. Researchers planned to compare asthma patients who had a severe COVID-19 infection with those who did not, tracking their lung function and symptoms for a year. Th…
Matched conditions: ASTHMA
Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Knowledge-focused
Last updated May 26, 2026 03:57 UTC
-
Scientists probe hidden clues in Preschoolers' severe asthma attacks
Knowledge-focused OngoingThis study examines 150 preschool children (ages 1 to under 5) hospitalized for a severe asthma attack. Researchers measure immune and inflammatory markers in blood and sputum to see if different wheezing patterns have different underlying causes. Children are followed until age …
Matched conditions: ASTHMA
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated May 26, 2026 03:52 UTC
-
Baby bacteria study: could early germs predict asthma?
Knowledge-focused OngoingThis study follows 180 infants from birth to age 1-2 years to see how bacteria in their upper airways change over time. Researchers want to learn if certain bacteria cause inflammation and lower lung function, which could lead to asthma. The study does not test any treatment, but…
Matched conditions: ASTHMA
Sponsor: Indiana University • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC
-
Asthma drug DUPIXENT under the microscope: how does it work in everyday life?
Knowledge-focused OngoingThis study tracks 718 asthma patients who are starting the medication DUPIXENT in real-world settings, not in a controlled lab. Researchers want to learn about the patients' backgrounds, how they use the drug, and how well it works over time. The goal is to gather long-term safet…
Matched conditions: ASTHMA
Sponsor: Regeneron Pharmaceuticals • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC
-
Asthma patients on dupixent: a closer look at Real-Life results
Knowledge-focused OngoingThis study follows 376 asthma patients aged 12 and older who are starting Dupixent in everyday medical practice. Researchers will collect information on patients' medical history, how they use the drug, and how well it controls their asthma. The goal is to understand real-world e…
Matched conditions: ASTHMA
Sponsor: Sanofi • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC
-
AI predicts hospital stays: a step toward smarter care?
Knowledge-focused TerminatedThis study aimed to see if a computer program could predict how long patients would stay in a home hospital program. Researchers used data from past patients to train the program. The study was withdrawn before enrolling any participants, so no results are available.
Matched conditions: ASTHMA
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 22, 2026 13:50 UTC
-
Asthma study aims to better understand the disease
Knowledge-focused TerminatedThis study looks at adults with asthma to learn more about their condition, including how severe it is and what factors affect it. Researchers will collect medical history and do lung function tests. The goal is to build a database that helps with future asthma research. About 25…
Matched conditions: ASTHMA
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC
-
New asthma drug tezepelumab under Real-World watch in italy
Knowledge-focused OngoingThis study watches 315 people with severe asthma in Italy who are starting a new drug called tezepelumab. Researchers will track their health, asthma attacks, and other conditions for up to two years. The goal is to see how well the drug works in real life, not just in a lab.
Matched conditions: ASTHMA
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC
-
New MRI study aims to uncover hidden lung damage in COVID and chronic disease
Knowledge-focused TerminatedThis study uses special MRI scans with inhaled gases to see how lungs work in people with asthma, COPD, or COVID-19 (including Long COVID). Researchers will track up to 160 participants over several years to understand how these diseases change the lungs over time. The goal is to…
Matched conditions: ASTHMA
Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust • Aim: Knowledge-focused
Last updated May 20, 2026 11:53 UTC
-
Asthma drug dosing study pulled before it began
Knowledge-focused TerminatedThis study was designed to find the best way to give the asthma drug terbutaline sulfate, comparing injection under the skin versus into a vein. It planned to enroll adults with asthma to measure how the drug moves through the body and affects breathing. However, the study was wi…
Matched conditions: ASTHMA
Phase: PHASE2, PHASE3 • Sponsor: Kanecia Obie Zimmerman • Aim: Knowledge-focused
Last updated May 19, 2026 11:46 UTC
-
City air and nighttime asthma: a clockwork connection?
Knowledge-focused OngoingThis study looks at how air pollution and the body's internal clock (circadian rhythm) interact in people with asthma. Researchers will measure tiny molecules called microRNAs in sputum samples from 20 adults with and without asthma, collected at different times over 48 hours. Th…
Matched conditions: ASTHMA
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated May 18, 2026 12:09 UTC
-
BREATH study tracks biologic drug effects in severe asthma
Knowledge-focused OngoingThis study observes 100 people with severe asthma who are taking biologic drugs. Researchers measure how the body's immune system reacts to the drug and whether that affects how well the treatment works. The goal is to better understand drug effectiveness and safety over time.
Matched conditions: ASTHMA
Sponsor: Samsung Medical Center • Aim: Knowledge-focused
Last updated May 18, 2026 12:08 UTC
-
Real-World asthma biologic patterns under study in china
Knowledge-focused OngoingThis study watches how Chinese asthma patients use biologic medicines and how well they work. About 202 people will be followed for a year while getting their usual care. The goal is to learn about treatment patterns, not to test a new drug.
Matched conditions: ASTHMA
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 18, 2026 12:06 UTC
-
AI potassium predictor study pulled before starting
Knowledge-focused TerminatedThis study aimed to see if a computer program could predict potassium levels in the blood using a simple heart monitor. Researchers planned to use data from patients treated at home. The study was withdrawn before any participants were enrolled, so no results are available.
Matched conditions: ASTHMA
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 18, 2026 12:01 UTC
-
Hong kong study reveals hidden overlap of asthma and COPD
Knowledge-focused OngoingThis study looks at 1,600 adults in Hong Kong who have been diagnosed with asthma or COPD to find out how many actually have both conditions (called Asthma-COPD Overlap). Researchers will track their health for 3 years to see how they do and whether their treatments match current…
Matched conditions: ASTHMA
Sponsor: Chinese University of Hong Kong • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC
-
Asthma mucus mystery: scientists peek inside lungs to find clues
Knowledge-focused TerminatedThis study aimed to understand why some people with asthma develop mucus plugs in their airways. Researchers planned to use a thin, camera-guided tube to collect samples from the lungs of 60 adults—some with asthma and mucus plugs, some with asthma but no plugs, and healthy volun…
Matched conditions: ASTHMA
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC